Effect of polymyxin B-immobilized fiber hemoperfusion on respiratory impairment, hepatocellular dysfunction, and leucopenia in a neonatal sepsis model

Mohamed Hamed Hussein, Ghada A. Daoud, Hiroki Kakita, Shin Kato, Tatenobu Goto, Michi Kamei, Kenji Goto, Yasuhiko Ozaki, Tetsuya Ito, Sumio Fukuda, Ineko Kato, Satoshi Suzuki, Takashi Hashimoto, Hajime Togari

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: Sepsis and septic shock remain a major source of morbidity and mortality in neonates despite advances in antimicrobials and aggressive supportive care. Our aim was to study the effects of polymyxin-B direct hemoperfusion (PMX-DHP) therapy on sepsis-induced respiratory impairment, liver dysfunction and leucopenia in a neonatal cecal ligation and perforation (CLP) model. Methods: Fourteen anesthetized and mechanically ventilated 3-day-old piglets underwent CLP and an arteriovenous extracorporeal circuit from 3 h until 6 h post-CLP, with a PMX column in the PMX-DHP treated group (7 piglets). Changes in oxygen saturation, PCO2, base excess, white blood cell (WBC) count, platelet count, hematocrit (Hct%), serum glutamate pyruvate transaminase (SGPT), and serum glutamic oxaloacetic transaminase were measured before CLP and at 1, 3 and 6 h after. Results: At 6 h, the PMX-DHP group showed lower Hct%, and SGPT in comparison to the control group, but higher oxygen saturation and WBC count. No effects on the platelet count were found. The survival times of the PMX-DHP group were longer than in control. Conclusion: PMX-DHP therapy limited the respiratory impairment, liver dysfunction and leucopenia in a neonatal septic model, which resulted in an improvement of survival time.

Original languageEnglish
Pages (from-to)187-193
Number of pages7
JournalPediatric Surgery International
Volume26
Issue number2
DOIs
Publication statusPublished - 01-02-2010
Externally publishedYes

Fingerprint

Hemoperfusion
Polymyxin B
Leukopenia
Ligation
Transaminases
Pyruvic Acid
Platelet Count
Leukocyte Count
Hematocrit
Liver Diseases
Glutamic Acid
Sepsis
Oxygen
Respiratory Therapy
Septic Shock
Aspartate Aminotransferases
Serum
Neonatal Sepsis
Morbidity
Control Groups

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Surgery

Cite this

Hussein, Mohamed Hamed ; Daoud, Ghada A. ; Kakita, Hiroki ; Kato, Shin ; Goto, Tatenobu ; Kamei, Michi ; Goto, Kenji ; Ozaki, Yasuhiko ; Ito, Tetsuya ; Fukuda, Sumio ; Kato, Ineko ; Suzuki, Satoshi ; Hashimoto, Takashi ; Togari, Hajime. / Effect of polymyxin B-immobilized fiber hemoperfusion on respiratory impairment, hepatocellular dysfunction, and leucopenia in a neonatal sepsis model. In: Pediatric Surgery International. 2010 ; Vol. 26, No. 2. pp. 187-193.
@article{5cb002dc60f44929b10688301532aff1,
title = "Effect of polymyxin B-immobilized fiber hemoperfusion on respiratory impairment, hepatocellular dysfunction, and leucopenia in a neonatal sepsis model",
abstract = "Purpose: Sepsis and septic shock remain a major source of morbidity and mortality in neonates despite advances in antimicrobials and aggressive supportive care. Our aim was to study the effects of polymyxin-B direct hemoperfusion (PMX-DHP) therapy on sepsis-induced respiratory impairment, liver dysfunction and leucopenia in a neonatal cecal ligation and perforation (CLP) model. Methods: Fourteen anesthetized and mechanically ventilated 3-day-old piglets underwent CLP and an arteriovenous extracorporeal circuit from 3 h until 6 h post-CLP, with a PMX column in the PMX-DHP treated group (7 piglets). Changes in oxygen saturation, PCO2, base excess, white blood cell (WBC) count, platelet count, hematocrit (Hct{\%}), serum glutamate pyruvate transaminase (SGPT), and serum glutamic oxaloacetic transaminase were measured before CLP and at 1, 3 and 6 h after. Results: At 6 h, the PMX-DHP group showed lower Hct{\%}, and SGPT in comparison to the control group, but higher oxygen saturation and WBC count. No effects on the platelet count were found. The survival times of the PMX-DHP group were longer than in control. Conclusion: PMX-DHP therapy limited the respiratory impairment, liver dysfunction and leucopenia in a neonatal septic model, which resulted in an improvement of survival time.",
author = "Hussein, {Mohamed Hamed} and Daoud, {Ghada A.} and Hiroki Kakita and Shin Kato and Tatenobu Goto and Michi Kamei and Kenji Goto and Yasuhiko Ozaki and Tetsuya Ito and Sumio Fukuda and Ineko Kato and Satoshi Suzuki and Takashi Hashimoto and Hajime Togari",
year = "2010",
month = "2",
day = "1",
doi = "10.1007/s00383-009-2476-x",
language = "English",
volume = "26",
pages = "187--193",
journal = "Pediatric Surgery International",
issn = "0179-0358",
publisher = "Springer Verlag",
number = "2",

}

Hussein, MH, Daoud, GA, Kakita, H, Kato, S, Goto, T, Kamei, M, Goto, K, Ozaki, Y, Ito, T, Fukuda, S, Kato, I, Suzuki, S, Hashimoto, T & Togari, H 2010, 'Effect of polymyxin B-immobilized fiber hemoperfusion on respiratory impairment, hepatocellular dysfunction, and leucopenia in a neonatal sepsis model', Pediatric Surgery International, vol. 26, no. 2, pp. 187-193. https://doi.org/10.1007/s00383-009-2476-x

Effect of polymyxin B-immobilized fiber hemoperfusion on respiratory impairment, hepatocellular dysfunction, and leucopenia in a neonatal sepsis model. / Hussein, Mohamed Hamed; Daoud, Ghada A.; Kakita, Hiroki; Kato, Shin; Goto, Tatenobu; Kamei, Michi; Goto, Kenji; Ozaki, Yasuhiko; Ito, Tetsuya; Fukuda, Sumio; Kato, Ineko; Suzuki, Satoshi; Hashimoto, Takashi; Togari, Hajime.

In: Pediatric Surgery International, Vol. 26, No. 2, 01.02.2010, p. 187-193.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of polymyxin B-immobilized fiber hemoperfusion on respiratory impairment, hepatocellular dysfunction, and leucopenia in a neonatal sepsis model

AU - Hussein, Mohamed Hamed

AU - Daoud, Ghada A.

AU - Kakita, Hiroki

AU - Kato, Shin

AU - Goto, Tatenobu

AU - Kamei, Michi

AU - Goto, Kenji

AU - Ozaki, Yasuhiko

AU - Ito, Tetsuya

AU - Fukuda, Sumio

AU - Kato, Ineko

AU - Suzuki, Satoshi

AU - Hashimoto, Takashi

AU - Togari, Hajime

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Purpose: Sepsis and septic shock remain a major source of morbidity and mortality in neonates despite advances in antimicrobials and aggressive supportive care. Our aim was to study the effects of polymyxin-B direct hemoperfusion (PMX-DHP) therapy on sepsis-induced respiratory impairment, liver dysfunction and leucopenia in a neonatal cecal ligation and perforation (CLP) model. Methods: Fourteen anesthetized and mechanically ventilated 3-day-old piglets underwent CLP and an arteriovenous extracorporeal circuit from 3 h until 6 h post-CLP, with a PMX column in the PMX-DHP treated group (7 piglets). Changes in oxygen saturation, PCO2, base excess, white blood cell (WBC) count, platelet count, hematocrit (Hct%), serum glutamate pyruvate transaminase (SGPT), and serum glutamic oxaloacetic transaminase were measured before CLP and at 1, 3 and 6 h after. Results: At 6 h, the PMX-DHP group showed lower Hct%, and SGPT in comparison to the control group, but higher oxygen saturation and WBC count. No effects on the platelet count were found. The survival times of the PMX-DHP group were longer than in control. Conclusion: PMX-DHP therapy limited the respiratory impairment, liver dysfunction and leucopenia in a neonatal septic model, which resulted in an improvement of survival time.

AB - Purpose: Sepsis and septic shock remain a major source of morbidity and mortality in neonates despite advances in antimicrobials and aggressive supportive care. Our aim was to study the effects of polymyxin-B direct hemoperfusion (PMX-DHP) therapy on sepsis-induced respiratory impairment, liver dysfunction and leucopenia in a neonatal cecal ligation and perforation (CLP) model. Methods: Fourteen anesthetized and mechanically ventilated 3-day-old piglets underwent CLP and an arteriovenous extracorporeal circuit from 3 h until 6 h post-CLP, with a PMX column in the PMX-DHP treated group (7 piglets). Changes in oxygen saturation, PCO2, base excess, white blood cell (WBC) count, platelet count, hematocrit (Hct%), serum glutamate pyruvate transaminase (SGPT), and serum glutamic oxaloacetic transaminase were measured before CLP and at 1, 3 and 6 h after. Results: At 6 h, the PMX-DHP group showed lower Hct%, and SGPT in comparison to the control group, but higher oxygen saturation and WBC count. No effects on the platelet count were found. The survival times of the PMX-DHP group were longer than in control. Conclusion: PMX-DHP therapy limited the respiratory impairment, liver dysfunction and leucopenia in a neonatal septic model, which resulted in an improvement of survival time.

UR - http://www.scopus.com/inward/record.url?scp=77649232969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649232969&partnerID=8YFLogxK

U2 - 10.1007/s00383-009-2476-x

DO - 10.1007/s00383-009-2476-x

M3 - Article

C2 - 19802625

AN - SCOPUS:77649232969

VL - 26

SP - 187

EP - 193

JO - Pediatric Surgery International

JF - Pediatric Surgery International

SN - 0179-0358

IS - 2

ER -